ASX Information
Company Announcements
Please note that to read the full articles you will need Adobe Acrobat Reader 5.0+ plugin.
You can download a free copy of Adobe Acrobat Reader by clicking here.
2008 Annual Report
October 2008
(Read full PDF)
APH 2008 Results Commentary
28 September 2008
(Read full PDF)
Preliminary Final Report
28 September 2008
(Read full PDF)
Directors Appointment and Appendix 3
12 August 2008
(Read full PDF)
Strides Asia Acquisition Completion
1 August 2008
(Read full PDF)
Results of Meeting
8 June 2008
(Read full PDF)
Strides Transaction Investor Presentation
29 May 2008
(Read full PDF)
Notice of Meeting
May 2008
(Read full PDF)
Explanatory Memorandum
May 2008
(Read full PDF)
Independent Expert's Report - Full Version
May 2008
(Read full PDF)
Genepharm signs definitive agreements with Strides
April 2008
(Read full PDF)
Appointment of Director - Resignation of Director
February 2008
(Read full PDF)
Become a Substantial Shareholder
February 2008
(Read full PDF)
GAA Half Year Financial Results Commentary
February 2008
(Read full PDF)
Genepharm to Acquire Strides Asia Business
February 2008
(Read full PDF)
Half Year Accounts
February 2008
(Read full PDF)
Investor Briefing
February 2008
(Read full PDF)
Trading Halt
February 2008
(Read full PDF)
Shareholder Update Dec07
December 2007
(Read full PDF)
Response to ASX Query
December 2007
(Read full PDF)
Appendix 3B
December 2007
(Read full PDF)
Appendix 3B
December 2007
(Read full PDF)
Cancellation of Shares Under Buy-Back
November 2007
(Read full PDF)
Daily Share Buy-Back Notice
November 2007
(Read full PDF)
Final Directors Interest Notice
November 2007
(Read full PDF)
Results of Meeting
November 2007
(Read full PDF)
Annual General Meeting 2007 - CEO`s Presentation
November 2007
(Read full PDF)
Annual General Meeting 2007 - Chairman's Address
November 2007
(Read full PDF)
 |
2007 Annual Report. |
Genepharm Australasia Ltd and Genepharm Asia Pacific Enterprises agree to terminate exclusive supply agreement
28 August 2007
(Read full PDF)
Genepharm’s full year results 2006/07
28 August 2007
(Read full PDF)
Results Presentation FY 2006/07
28 August 2007
(Read full PDF)
Appendix 4E Preliminary final report.
30 June 2007
(Read full PDF)
Genepharm boosts generic drug range to 95 per cent.
14 June 2007
(Read full PDF)
Genepharm strengthens management team.
13 June 2007
(Read full PDF)
Investor Update.
11 May 2007
(Read full PDF)
Appendix 4C - Quarterly Report March 2007.
30 April 2007
(Read full PDF)
Investor Update.
30 April 2007
(Read full PDF)
Issue of Shares to Staff.
16 April 2007
(Read full PDF)
Change of Directors Interest Notice.
28 March 2007
(Read full PDF)
Appendix 3X Initial Directors Interest Notice.
14 March 2007
(Read full PDF)
Appendix 4D - Half Yearly Report December 2006.
27 February 2007
(Read full PDF)
Half Year Financial Report.
27 February 2007
(Read full PDF)
Half Year Results - Commentary.
27 February 2007
(Read full PDF)
Appointment of New Director.
19 February 2007
(Read full PDF)
Appendix 4C - Quarterly Report September 2006.
31 January 2007
(Read full PDF)
 |
Loyalty Programme Prospectus |
Annual General Meeting Presentation.
29 November 2006
(Read full PDF)
Healthcare Conference Presentation.
16 November 2006
(Read full PDF)
Shareholder Update.
15 November 2006
(Read full PDF)
Appendix 4C - Quarterly Report September 2006.
30 October 2006
(Read full PDF)
Notice of Annual General Meeting 2006.
26 October 2006
(Read full PDF)
Genepharm Alliance with Primary Health Care.
27 September 2006
(Read full PDF)
Genepharm Alliance with Primary Health Care.
27 September 2006
(Read full PDF)
WOW Loyalty Program Prospectus.
14 September 2006
(Read full PDF)
Genepharm to acquire EpiPharm dermatology range.
12 September 2006
(Read full PDF)
Appendix 4E - Preliminary Final Report.
11 September 2006
(Read full PDF)
Full Year Results to June 2006 - Commentary.
11 September 2006
(Read full PDF)
 |
2006 Annual Report. |
Genepharm To Launch Generic Pravastatin.
26 July 2006
(Read full PDF)
Appendix 4C - Quarterly Report June 2006.
24 July 2006
(Read full PDF)
Genepharm Wins Tasmanian Hospitals Supply Tender.
19 July 2006
(Read full PDF)
Genepharm Settles Douglas Acquisition.
14 July 2006
(Read full PDF)
Genepharm Completes $60 million Capital Raising.
11 July 2006
(Read full PDF)
Investor Presentation.
23 June 2006
(Read full PDF)
Genepharm Acquires Douglas Pharmaceuticals Australia for $70million.
5 June 2006
(Read full PDF)
 |
Prospectus - Rights Issue. |
A renounceable entitlement issue of ordinary shares on the basis of 2 new ordinary shares for
every 3 ordinary shares held at an issue price of $1.00
each.
The proceeds of the issue will be used by the Company to fund the acquisition of Douglas Pharmaceuticals Australia Limited.
Genepharm makes significant acquisition.
29 May 2006
(Read full PDF)
Sales and Product Update.
1 May 2006
(Read full PDF)
Appendix 4C - Quarterly Report March 2006.
28 April 2006
(Read full PDF)
Cancer Drugs Approved by TGA.
9 March 2006
(Read full PDF)
Half Year Financial Report.
28 February 2006
(Read full PDF)
Appendix 4D - Half Yearly Report December 2005.
1 February 2006
(Read full PDF)
Genepharm Registers Australia's Biggest Selling Generic Drug.
1 February 2006
(Read full PDF)
Appendix 4C - Quarterly Report December 2005.
24 January 2005
(Read full PDF)
AGM Presentation.
30 November 2005
(View full Presentation)
Appendix 4C - Quarterly Report September 2005.
01 November 2005
(Read full PDF)
 |
2005 Annual Report. |
Appendix 4E - Preliminary Final Report.
9 September 2005
(Read full PDF)
Shareholder Update: Genepharm On Budget and On Track for 2005.
9 September 2005
(Read full PDF)
Appendix 4C - Quarterly Report June 2005.
28 July 2005
(Read full PDF)
Genepharm Secures Pharmacy Drug Distribution Agreements.
28 June 2005
(Read full PDF)
Investor Presentation.
3 May 2005
(View full Presentation)
Genepharm Adds New Blockbuster to Registration Pipeline.
26 April 2005
(Read full PDF)
Appendix 4C - Quarterly Report March 2005.
21 April 2005
(Read full PDF)
Genepharm Ahead of Cashflow Forecasts.
21 April 2005
(Read full PDF)
Shares to be Released from Escrow.
19 April 2005
(Read full PDF)
Appendix 4C - Quarterly Report December 2004.
21 January 2005
(Read full PDF)
Shareholder Update - January 2005.
14 January 2005
(Read full PDF)
CEO's Presentation to Securities Institute.
26 November 2004
(View full Presentation)
Chairman's & CEO's AGM Reports to Shareholders.
24 November 2004
(Read full PDF)
Genepharm Begins Registration of Simvastatin.
25 October 2004
(Read full PDF)
Appendix 4C - Quarterly Report September 2004.
21 October 2004
(Read full PDF)
 |
2004 Annual Report. |
Pharma Sales High-flier Joins Genepharm.
10 September 2004
(Read full PDF)
Appendix 4E - Preliminary Final Report.
20 August 2004
(Read full PDF)
Genepharm Begins Registration of 5 Cancer Drugs.
20 August 2004
(Read full PDF)
Appendix 4C - Quarterly Report June 2004.
29 July 2004
(Read full PDF)
 |
Initial Public Offering Prospectus (summary). |
A summary of the main sections of the Genepharm Australasia IPO Prospectus. The Genepharm Australasia Share Offer closed on 31st May 2004.